Advertisement
Advertisement

CELC

CELC logo

Celcuity Inc. Common Stock

92.78
USD
Sponsored
-0.47
-0.50%
Aug 07, 15:59 UTC -4
Closed
exchange

After-Market

93.89

+1.11
+1.20%

Celcuity Inc. Common Stock Profile

About

Celcuity Inc. is a cellular analysis company. It engaged in discovering new cancer sub-types and commercializing diagnostic tests designed to significantly improve the clinical outcomes of cancer patients treated with targeted therapies. The company's proprietary CELx diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular activity driving a patient's cancer and the targeted therapy. Celcuity Inc. is based in Minneapolis, United States.

Info & Links

CEO

Brian F. Sullivan

Headquarters

16305 36TH AVENUE NORTH, SUITE 100
MINNEAPOLIS, MN 55446, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.celcuity.com

Auditor

Boulay PLLP

Share holders

101

Employees

155

Celcuity Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

4.58B

Enterprise Value

4.76B

Enterprise Value/EBITDA(ttm)

-26.06

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

83.91

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-244.61%

Return on Invested Capital(ttm)

-67.62%

Return on Assets(ttm)

-50.22%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-182.55M

Net Income Available to Common(ttm)

-192.89M

Diluted EPS(ttm)

-3.90

Share Statistics

Beta (5Y Monthly)

0.20

52-Week Change

109.96%

S&P 500 52-Week Change

22.36%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

48.77M

Dividend Yield

0.00%

Float4

42.27M

% Held by Insiders

13.33%

% Held by Institutions

63.33%

Balance Sheet

Total Cash(mrq)

387.06M

Total Cash Per Share(mrq)

7.94

Total Debt(mrq)

323.43M

Total Debt/Equity(mrq)

604.26%

Current Ratio(mrq)

12.31%

Quick Ratio(mrq)

12.31%

Book Value Per Share(mrq)

1.11

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.01

Free Cash Flow(ytd)

-55.35M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement